Back to today’s briefing

Story perspectives

Trump Secures Major Price Cuts for Weight-Loss Drugs

11/11/2025

50 12

Summary

Story summary

U.S. President Donald Trump announced on November 9, 2025 a deal to significantly reduce prices for weight-loss drugs from Eli Lilly and Novo Nordisk.
The agreement targets lower costs for Medicare and Medicaid patients and for people paying out of pocket.
The article suggests that such negotiations should not favor large corporations aligned with Trump’s interests.

1 of 1

Story summary

U.S. President Donald Trump announced on November 9, 2025 a deal to significantly reduce prices for weight-loss drugs from Eli Lilly and Novo Nordisk.
The agreement targets lower costs for Medicare and Medicaid patients and for people paying out of pocket.
The article suggests that such negotiations should not favor large corporations aligned with Trump’s interests.